CDC Webpage: Pause In Use of Johnson & Johnson’s Janssen COVID-19 Vaccine

The CDC has a new webpage to answer your questions about the recommended pause in the use the Johnson & Johnson’s Janssen COVID-19 vaccine. Find it here:

Here is what important to know if you recently received the J&J COVID-19 vaccine:

➡️ If you received the vaccine more than three weeks ago, the risk of developing a blood clot is likely very low at this time.

➡️ If you received the vaccine within the last three weeks, your risk of developing a blood clot is also very low and that risk will decrease over time.

➡️ Contact your healthcare provider and seek medical treatment urgently if you develop any of the following symptoms:
• severe headache
• backache
• new neurologic symptoms
• severe abdominal pain
• shortness of breath
• leg swelling
• tiny red spots on the skin
• new or easy bruising

If you are scheduled to get the J&J/Janssen COVID-19 vaccine, please work with your vaccine provider to reschedule your appointment to receive another authorized and recommended COVID-19 vaccine. There are two other COVID-19 vaccines authorized and recommended for use in the United States: Pfizer-BioNTech and Moderna.

If you experience any adverse events after vaccination, report them to v-safe and the Vaccine Adverse Event Reporting System (VAERS)


CDC webpage:

Leave a Reply